Skip to content

The efficacy and safety of microneedling-assisted percutaneous absorption of triamcinolone acetonide solution: A pilot study

The efficacy and safety of microneedling-assisted percutaneous absorption of triamcinolone acetonide solution: A pilot study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250318001
Enrollment
12
Registered
2025-03-18
Start date
2023-11-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer triamcinolone acetonide, microneedling radio-frequency, percutaneous drug absorbtion

Interventions

Triamcinolone acetonide was drop to patient forearm. It was then leave for 6 hours. Clear tape was striped to patient forearm. the level of triamcinolone acetonide was measured.,Microneedle Depth 0.5m
Experimental Device,Experimental Device,Experimental Device,Experimental Device,Experimental Device,Experimental Device,Experimental Device,Experimental Device
TA only,Microneedle Depth 0.5mm RF level 2 (420mJ) with TA,Microneedle Depth 0.5mm RF level 5 (1300mJ) with TA,Microneedle Depth 2.5mm RF level 2 (420mJ) with TA,Microneedle Depth 2.5mm RF level 5 (13

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. age 18 to 60 years old 2. healthy volunteer with no skin lesion at forearm 3. consent to receive treatment

Exclusion criteria

Exclusion criteria: 1. pregnancy or breastfeeding 3 months prior to study 2. dermatitis or active skin lesion at forearm 3. have prior treatment including laser, skin toning at forearm 4 weeks prior to study 4. steroid hypersensitivity 5. have photohypersitivity rash 6. chronic use of steroid, heavy smoking

Design outcomes

Primary

MeasureTime frame
the level of triamcinolone acetonide solution after study Ultra high-performance liquid chromatography

Secondary

MeasureTime frame
transepidermal water loss after study transepidermal water loss (TEWL)meter

Countries

Thailand

Contacts

Public ContactRungsima Wanitphakdeedecha

Faculty of Medicine Siriraj Hospital, Mahidol University

rungsima.wan@mahidol.ac.th6616406300

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026